140 related articles for article (PubMed ID: 36177621)
1. The LL-37 Antimicrobial Peptide as a Treatment for Systematic Infection of
Zarei-Mehrvarz E; Fahimirad S; Ghaznavi-Rad E; Abbasian SS; Abtahi H
Protein Pept Lett; 2023; 30(1):44-53. PubMed ID: 36177621
[TBL] [Abstract][Full Text] [Related]
2. OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii.
Lin MF; Tsai PW; Chen JY; Lin YY; Lan CY
PLoS One; 2015; 10(10):e0141107. PubMed ID: 26484669
[TBL] [Abstract][Full Text] [Related]
3. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii.
Feng X; Sambanthamoorthy K; Palys T; Paranavitana C
Peptides; 2013 Nov; 49():131-7. PubMed ID: 24071034
[TBL] [Abstract][Full Text] [Related]
4. Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii.
Sakoulas G; Rose W; Berti A; Olson J; Munguia J; Nonejuie P; Sakoulas E; Rybak MJ; Pogliano J; Nizet V
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872080
[TBL] [Abstract][Full Text] [Related]
5. Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii.
Lee JY; Hong YK; Ko KS
Diagn Microbiol Infect Dis; 2020 Apr; 96(4):114965. PubMed ID: 32019695
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
[TBL] [Abstract][Full Text] [Related]
7. Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.
Barksdale SM; Hrifko EJ; van Hoek ML
Dev Comp Immunol; 2017 May; 70():135-144. PubMed ID: 28089718
[TBL] [Abstract][Full Text] [Related]
8. Octopromycin: Antibacterial and antibiofilm functions of a novel peptide derived from Octopus minor against multidrug-resistant Acinetobacter baumannii.
Rajapaksha DC; Jayathilaka EHTT; Edirisinghe SL; Nikapitiya C; Lee J; Whang I; De Zoysa M
Fish Shellfish Immunol; 2021 Oct; 117():82-94. PubMed ID: 34311097
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction.
Kong D; Hua X; Zhou R; Cui J; Wang T; Kong F; You H; Liu X; Adu-Amankwaah J; Guo G; Zheng K; Wu J; Tang R
Microbiol Spectr; 2022 Oct; 10(5):e0131222. PubMed ID: 36190276
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activities and action mechanism of the novel antimicrobial peptide Hylin a1 and its analog peptides against Acinetobacter baumannii infection.
Park HJ; Kang HK; Park E; Kim MK; Park Y
Eur J Pharm Sci; 2022 Aug; 175():106205. PubMed ID: 35561952
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification and investigation of antibacterial activity of a novel hybrid peptide LL37/hBD-129 by applied comprehensive computational and experimental approaches.
Abbasi M; Behmard E; Yousefi MH; Shekarforoush SS; Mahmoodi S
Arch Microbiol; 2023 Apr; 205(5):199. PubMed ID: 37069440
[TBL] [Abstract][Full Text] [Related]
12. Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.
Wanmakok M; Orrapin S; Intorasoot A; Intorasoot S
Gene; 2018 Sep; 671():1-9. PubMed ID: 29859288
[TBL] [Abstract][Full Text] [Related]
13. Systemic Responses of Multidrug-Resistant
Liu C; Shan B; Qi J; Ma Y
Front Cell Infect Microbiol; 2017; 7():466. PubMed ID: 29164074
[TBL] [Abstract][Full Text] [Related]
14. LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides.
Narh JK; Casillas-Vega NG; Zarate X
Appl Microbiol Biotechnol; 2024 Dec; 108(1):126. PubMed ID: 38229302
[TBL] [Abstract][Full Text] [Related]
15. Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.
Peng SY; You RI; Lai MJ; Lin NT; Chen LK; Chang KC
Sci Rep; 2017 Sep; 7(1):11477. PubMed ID: 28904355
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial and pro-angiogenic properties of soluble and nanoparticle-immobilized LL37 peptides.
Comune M; Rai A; Palma P; TondaTuro C; Ferreira L
Biomater Sci; 2021 Dec; 9(24):8153-8159. PubMed ID: 34787608
[TBL] [Abstract][Full Text] [Related]
17. Wound healing activity of the human antimicrobial peptide LL37.
Ramos R; Silva JP; Rodrigues AC; Costa R; Guardão L; Schmitt F; Soares R; Vilanova M; Domingues L; Gama M
Peptides; 2011 Jul; 32(7):1469-76. PubMed ID: 21693141
[TBL] [Abstract][Full Text] [Related]
18. Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.
Barksdale SM; Hrifko EJ; Chung EM; van Hoek ML
BMC Microbiol; 2016 Aug; 16(1):189. PubMed ID: 27542832
[TBL] [Abstract][Full Text] [Related]
19. LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.
Bhattacharjya S; Zhang Z; Ramamoorthy A
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540740
[TBL] [Abstract][Full Text] [Related]
20. Collagen tethering of synthetic human antimicrobial peptides cathelicidin LL37 and its effects on antimicrobial activity and cytotoxicity.
Lozeau LD; Grosha J; Kole D; Prifti F; Dominko T; Camesano TA; Rolle MW
Acta Biomater; 2017 Apr; 52():9-20. PubMed ID: 28017866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
